Author

M. P. Goetz

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1

Frequent Co-Authors

L. Wang· 2 shared A. Moreno Aspitia· 1 shared D. W. Northfelt· 1 shared J. C. Boughey· 1 shared J. Cairns· 1 shared J. Ingle· 1 shared J. M. Carter· 1 shared J. P. Sinnwell· 1 shared

Activity by Year

2019-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

L. Wang

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Integration of multi-omics data shows downregulation of mismatch repair, purin, and tublin pathways in AR-negative triple-negative chemotherapy-resistant breast tumors

X. Tang, K. J. Thompson, K. R. Kalari, J. P. Sinnwell, V. Suman, P. T. Vedell, S. A. McLaughlin, D. W. Northfelt, A. Moreno Aspitia, R. J. Gray, J. M. Carter, R. Weinshilboum, L. Wang, J. C. Boughey, M. P. Goetz

The paper identifies a 17-gene signature from post-NAC biopsies that shows downregulation of immune and pathway genes associated with TNBC recurrence.

bioRxiv · May 16, 2022 · PreprintCancer Biology

MIR2052HG regulates ERα levels and aromatase inhibitor resistance through LMTK3 by recruiting EGR1

J. Cairns, J. Ingle, K. Kalari, L. E. Shepherd, M. Kubo, M. P. Goetz, R. M. Weinshilboum, L. Wang

This study identifies MIR2052HG's role in regulating LMTK3 and ERα levels, contributing to aromatase inhibitor resistance in breast cancer.

bioRxiv · Jan 9, 2019Cancer Biology